Advertisement

BASELINE AMYLOID (18F-AV-45 PET) DISTRIBUTIONS BY CONSENSUS DIAGNOSIS FROM THE BIOMARKERS OF ALZHEIMER’S DISEASE IN ADULTS WITH DOWN SYNDROME (ADDS) CONSORTIUM

      The ADDS study, part of the Alzheimer’s Biomarkers Consortium-Down Syndrome (ABC-DS)[1], aims to identify biomarkers associated with AD in older adults with DS. Here we report on baseline brain amyloid (18F-AV-45) by consensus diagnosis of the 66 participants who completed PET scans.
      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'